Merck KGaA gets a thumbs up for once-dead MS drug; Aveo shares soar as tivo makes a comeback
→ Cladribine is back. Once given up for dead by Merck KGaA, the multiple sclerosis drug has been endorsed by the CHMP in Europe …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
